MannKind Corporation
INHALED IMATINIB FOR PULMONARY HYPERTENSION

Last updated:

Abstract:

Methods of treatment of pulmonary hypertension comprising dry powder inhalation administration of imatinib, a pharmaceutically acceptable salt, or a derivative thereof, are provided. Dry powder inhalable compositions comprising imatinib, a pharmaceutically acceptable salt, or a derivative thereof, are also provided as well as methods of making the same.

Status:
Application
Type:

Utility

Filling date:

16 Nov 2021

Issue date:

19 May 2022